Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema - A case report

Indian J Ophthalmol. 2019 Jun;67(6):975-977. doi: 10.4103/ijo.IJO_1938_18.

Abstract

A 13-year-old boy with a 4-year history of idiopathic pediatric uveitis and recurrent uveitic macular edema had failed conventional immunomodulatory therapy and presented to us with a vision of 6/24 [right eye (OD)] and 6/9 [left eye (OS)]. Fluorescein angiography showed diffuse vascular leakage along with cystoid macular edema (CME). Intravenous tocilizumab (10 mg/kg body) was given as 14 injections over 12 months. Repeat fluorescein angiography every 3 months showed a dramatic improvement in the vascular leakage and resolution of CME. At 13 months OF follow-up, vision had improved to 6/9p (OD) and 6/6(OS) with no recurrence of inflammation or CME.

Keywords: Biologics; cystoid macular edema; idiopathic; pediatric uveitis; tocilizumab.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Injections, Intravenous
  • Macula Lutea / pathology*
  • Macular Edema / complications
  • Macular Edema / diagnosis
  • Macular Edema / drug therapy*
  • Male
  • Tomography, Optical Coherence
  • Uveitis / complications
  • Uveitis / diagnosis
  • Uveitis / drug therapy*
  • Visual Acuity

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab